Cover Image

No selection of CXCR4-using variants in cell reservoirs of dual-mixed HIV infected patients receiving suppressive maraviroc therapy

Saved in:

Bibliographic Details
Main Authors:	J. Izopet (Author), S. Raymond (Author), F. Nicot (Author), N. Jeanne (Author), P. Delobel (Author)
Format:	Book
Published:	Elsevier, 2015-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Markers of HIV reservoir size and immune activation after treatment in acute HIV infection with and without raltegravir and maraviroc intensification
by: Jintanat Ananworanich, et al.
Published: (2015)

Maraviroc: a review of its use in HIV infection and beyond
by: Woollard SM, et al.
Published: (2015)

30LB Maraviroc administration is associated to reversion of latent HIV-1 through NFkB in ART suppressed patients
by: N. Madrid-Elena, et al.
Published: (2016)

Short-term maraviroc exposure, a clinical approach to decide on maraviroc prescription in HIV-1-infected treatment-naïve patients
by: Gonzalez-Serna A, et al.
Published: (2016)

Development and evaluation of mucoadhesive bigel containing tenofovir and maraviroc for HIV prophylaxis
by: Margaret O. Ilomuanya, et al.
Published: (2020)

Targeting CXCL12/CXCR4 Signaling with AMD3100 Might Selectively Suppress CXCR4+ T-Cell Chemotaxis Leading to the Alleviation of Chronic Prostatitis
by: Zhang M, et al.
Published: (2022)

Natural scrub typhus antibody suppresses HIV CXCR4(X4) viruses
by: George Watt, et al.
Published: (2013)

Suppression of the HIV-1 reservoir with a potent Tat inhibitor
by: S. Valente, et al.
Published: (2015)

Persistent HIV reservoir suppression by (-)-hopeaphenol, a plant-derived stilbenoid
by: I. Tietjen, et al.
Published: (2019)

15 Pulmonary T cells and HIV reservoirs in adults under suppressive ART
by: CeciliaT Costiniuk, et al.
Published: (2017)

O3 Quantifying and characterising the HIV reservoir in virally suppressed patients
by: Pieter Pannus, et al.
Published: (2016)

Measurement and characterization of the latent reservoir for HIV-1 in patients receiving solid organ transplant
by: A. Martin, et al.
Published: (2017)

CXCR4-usage HIV-1 strains isolated from blood and cerebrospinal fluid in subjects on suppressive antiretroviral therapy
by: A. Nath, et al.
Published: (2019)

Maraviroc reactivates HIV with a potency similar to that of other latency reversing drugs without inducing toxicity in CD8 T cells
by: S. Moreno, et al.
Published: (2019)

Fármacos recentes usados para o tratamento da infecção pelo HIV-1: enfuvirtida, maraviroc, raltegravir e etravirina
by: M.A. Brito
Published: (2011)

PP 1.30 - 00159 Dating HIV-1 reservoir formation in ARV-suppressed Ugandans
by: E.N. Kankaka, et al.
Published: (2022)

Sex differences in the latent reservoir of virally suppressed HIV-1 infected individuals living in Rakai, Uganda
by: T.C. Quinn, et al.
Published: (2019)

The CCR5-agonist maraviroc reverses HIV latency, results from ex vivo studies and a randomized placebo controlled clinical trial
by: J. Symons, et al.
Published: (2017)

Immunologic Effects of Maraviroc in HIV-Infected Patients with Severe CD4 Lymphopenia Starting Antiretroviral Therapy: A Sub-Study of the CADIRIS Trial
by: Pablo Francisco Belaunzarán-Zamudio, et al.
Published: (2017)

Dual-affinity re-targeting (DART) proteins overcome viral diversity to deplete the latent HIV-1 reservoir
by: J.M. Sung, et al.
Published: (2015)

HIV Reservoir Characterization Symposium
by: Eva Malatinkova, et al.
Published: (2017)

Quantitation of the CD4+ T cell and macrophage reservoirs in SIV-infected ART-suppressed macaques: two functional latent reservoirs
by: J. Clements, et al.
Published: (2017)

Interactions of selected cardiovascular active natural compounds with CXCR4 and CXCR7 receptors: a molecular docking, molecular dynamics, and pharmacokinetic/toxicity prediction study
by: Hussam Aly Sayed Murad, et al.
Published: (2022)

50LB Central nervous system impact of vorinostat, hydroxychloroquine and maraviroc combination therapy followed by treatment interruption in individuals treated during acute HIV infection
by: E. Kroon, et al.
Published: (2016)

The Role of the CXCL12/CXCR4/CXCR7 Chemokine Axis in Cancer
by: Yi Shi, et al.
Published: (2020)

OP 5.2 - 00070 Characterization of a dual PTPN1/PTPN2 inhibitor to target latent HIV reservoirs
by: A. Bosque, et al.
Published: (2022)

19 Quantification and correlates of the replication competent HIV-1 latent viral reservoir in a virally suppressed Ugandan population
by: J.L. Prodger, et al.
Published: (2016)

Chemokine Receptor 2 (CXCR2) Gene Variants and Their Association with Periodontal Bacteria in Patients with Chronic Periodontitis
by: Denisa Kavrikova, et al.
Published: (2019)

CNS reservoirs for HIV: implications for eradication
by: Joanna Hellmuth, et al.
Published: (2015)

Regulatory T cells: the ultimate HIV reservoir?
by: Joseph Rocco, et al.
Published: (2018)

Neutraplex nanoparticles to target HIV reservoirs
by: C. Lavigne, et al.
Published: (2015)

Intensification of ART with ABX464 decreases the total HIV reservoir and HIV transcription initiation in CD4 T cells from HIV-infected ART-suppressed individuals
by: S. Moron-Lopez, et al.
Published: (2019)

OA3-5 LB Effect of vorinostat, hydroxychloroquine and maraviroc combination therapy on viremia following treatment interruption in individuals initiating ART during acute HIV infection
by: E. Kroon, et al.
Published: (2016)

Tissue macrophages are a major viral reservoir in male urethra of HIV-1-infected individuals under suppressive antiretroviral therapy
by: M. Bomsel, et al.
Published: (2017)

Advances in CXCR7 Modulators
by: Nicole Lounsbury
Published: (2020)

Defining HIV and SIV Reservoirs in Lymphoid Tissues
by: Claire Deleage, et al.
Published: (2016)

HIV antibodies as markers of HIV systemic reservoir and replication activity
by: S.M. Keating, et al.
Published: (2015)

CCR5 Antagonist Maraviroc Inhibits Acute Exacerbation of Lung Inflammation Triggered by Influenza Virus in Cigarette Smoke-Exposed Mice
by: Maximiliano Ruben Ferrero, et al.
Published: (2021)

27 Therapeutic immune recovery prevents emergence of CXCR4-tropic HIV-1
by: J. Bader, et al.
Published: (2016)

SDF-1/CXCL12 and CXCR4 gene variants, and elevated serum SDF-1 levels are associated with preeclampsia
by: Savas Karakus, et al.
Published: (2017)